What is Asimily?
Founded in 2017 and headquartered in Sunnyvale, California, Asimily provides a robust Internet of Medical Things (IoMT) risk management platform. The company's solution empowers businesses to gain comprehensive visibility into their medical and IoT device inventory, identify and mitigate critical security risks, and optimize patching costs. Asimily's technology is crucial for healthcare organizations and other enterprises managing a growing landscape of connected devices, ensuring operational continuity and data security.
How much funding has Asimily raised?
Asimily has raised a total of $10M across 1 funding round:
Unspecified
$10M
Unspecified (2021): $10M with participation from Ridge Ventures, Eileses Capital, New Leaf Venture Partners, Engineering Capital, and Inventus Capital Partners
Key Investors in Asimily
Ridge Ventures
Ridge Ventures is an early-stage venture capital firm specializing in seed and Series A funding for software industry innovators, focusing on experienced founders and revenue-driven growth.
Eileses Capital
Eileses Capital is a venture capital firm dedicated to supporting companies with bold ideas through capital investment and effective execution, aiming to foster growth and development across various sectors.
New Leaf Venture Partners
New Leaf Venture Partners is a venture capital firm focused on funding innovative companies within the healthcare sector, aiming to drive advancements that improve patient care and health outcomes.
What's next for Asimily?
With its major enterprise-level funding, Asimily is poised for significant growth and innovation. The company is likely to focus on expanding its market reach, enhancing its platform's capabilities to address evolving IoMT threats, and forging strategic partnerships within the healthcare and technology sectors. This latest capital infusion signals a strong commitment from investors to support Asimily's trajectory as a leader in securing the complex ecosystem of connected medical devices.
See full Asimily company page
